These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 14205890)

  • 1. SEROLOGICAL STUDIES ON CHOLERA. I. ANTIBODY LEVELS OBSERVED IN VACCINATED AND CONVALESCENT PERSONS.
    BERAN GW
    Am J Trop Med Hyg; 1964 Sep; 13():698-707. PubMed ID: 14205890
    [No Abstract]   [Full Text] [Related]  

  • 2. SEROLOGICAL STUDIES ON CHOLERA. II. ANTIBODY LEVELS OBSERVED IN EXPERIMENTALLY VACCINATED MONKEYS.
    BERAN GW
    Am J Trop Med Hyg; 1964 Sep; 13():708-15. PubMed ID: 14205891
    [No Abstract]   [Full Text] [Related]  

  • 3. SEROLOGICAL RESPONSES IN MAN TO A SINGLE SMALL DOSE OF CHOLERA VACCINE WITH SPECIAL REFERENCE TO THE LACK OF INFLUENCE OF ABO BLOOD GROUP ON NATURAL ANTIBODY OR IMMUNOLOGICAL RESPONSIVENESS.
    FINKELSTEIN RA; POWELL CJ; WOODROW JC; KREVANS JR
    Bull Johns Hopkins Hosp; 1965 Mar; 116():152-60. PubMed ID: 14280312
    [No Abstract]   [Full Text] [Related]  

  • 4. AGGLUTINATING, LETHAL TOXIN AND E1 TOR HAEMOLYSIN NEUTRALIZING POTENCY OF SERA IN CHOLERA.
    FELSENFELD O; NASUNIYA N; WATANABE Y; PENA A; DALE BN
    Bull World Health Organ; 1964; 30(6):833-44. PubMed ID: 14215189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE 1961 CHOLERA EPIDEMIC IN MANILA, REPUBLIC OF THE PHILIPPINES.
    WALLACE CK; FABIE AE; MANGUBAT O; VELASCO E; JUINIO C; PHILLIPS RA
    Bull World Health Organ; 1964; 30(6):795-810. PubMed ID: 14215186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STUDIES ON THE ROLE OF ACTIVE IMMUNIZATION IN THE PREVENTION OF CHOLERA EL TOR.
    BERAN GW; ELVINA O; FLORENDO FN
    J Philipp Med Assoc; 1964 Feb; 40():122-35. PubMed ID: 14244111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current problems of epidemiology and prevention of El Tor cholera].
    Teodorovici G
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):1-7. PubMed ID: 5552559
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines. Preliminary report; Philippines Cholera Committee.
    Philippines Cholera Committee
    Bull World Health Organ; 1965; 32(5):603-25. PubMed ID: 5294176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heat on cholera vibrio: its implication for vaccine manufacture.
    Ghosh HK
    Med J Malaya; 1969 Mar; 23(3):179-80. PubMed ID: 4240070
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of reactions and serological response to cholera vaccines in a controlled field trial conducted in the USSR.
    Burgasov PN; Sumarokov AA; Lelikov VL; Marcuk LM; Fedenev VG; Dzaparidze MN; Karaeva LT; Derteva II
    Bull World Health Organ; 1976; 54(2):163-70. PubMed ID: 798636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.
    Capeding MRZ; Gonzales MLAM; Dhingra MS; D'Cor NA; Midde VJ; Patnaik BN; Thollot Y; Desauziers E
    Hum Vaccin Immunother; 2017 Oct; 13(10):2232-2239. PubMed ID: 28910563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)].
    Gateff C; Dodin A; Wiart J
    Ann Microbiol (Paris); 1975; 126(2):231-46. PubMed ID: 1098542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae.
    Mosley WH; McCormack WM; Ahmed A; Chowdhury AK; Barui RK
    Bull World Health Organ; 1969; 40(2):187-97. PubMed ID: 5306539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRELIMINARY STUDIES ON THE DEVELOPMENT OF A LIVE ORAL VACCINE FOR ANTI-CHOLERA IMMUNIZATION.
    MUKERJEE S
    Bull World Health Organ; 1963; 29(6):753-66. PubMed ID: 14107748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological response to cholera revaccination in a semi-closed community in Calcutta.
    Sinha R; Deb BC; Ganguly R; De SP; Abou-Gareeb AH; Shrivastava DL
    Bull World Health Organ; 1970; 43(3):407-12. PubMed ID: 5312995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEROLOGICAL STUDIES IN EL TOR CHOLERA.
    BASACA-SEVILLA V; PESIGAN TP
    J Philipp Med Assoc; 1964 Dec; 40():SUPPL:1039-84. PubMed ID: 14282496
    [No Abstract]   [Full Text] [Related]  

  • 18. A test of antigenicity for the selection of strains for inclusion in cholera vaccines.
    Finkelstein RA; Pongpairojana S
    Bull World Health Organ; 1968; 39(2):247-59. PubMed ID: 5303406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.
    Azurin JC; Cruz A; Pesigan TP; Alvero M; Camena T; Suplido R; Ledesma L; Gomez CZ
    Bull World Health Organ; 1967; 37(5):703-27. PubMed ID: 5300874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convalescent carriers of Vibrio cholerae. Detection and detailed investigation.
    Pierce NF; Banwell JG; Gorbach SL; Mitra RC; Mondal A
    Ann Intern Med; 1970 Mar; 72(3):357-64. PubMed ID: 4906111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.